|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,028.00 GBX | +3.71% |
|
+6.84% | +37.47% |
| 05-07 | Pirc advises JP Morgan shareholders to vote for resolution to appoint independent board chairman | RE |
| 04-29 | Morgan Stanley raises ITM; Goldman likes Ceres | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.21 | 5.4 | 5.17 | 4.59 | 4.45 | |||||
Return on Total Capital | 17.41 | 16.48 | 15.55 | 14.52 | 16.09 | |||||
Return On Equity % | 27.11 | 22.79 | 21.9 | 19.44 | 18.3 | |||||
Return on Common Equity | 27.08 | 22.76 | 21.87 | 19.5 | 18 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 12.9 | 14.64 | 15.08 | 14.86 | 12.44 | |||||
SG&A Margin | 9.12 | 10.65 | 11.31 | 11.47 | 9.57 | |||||
EBITDA Margin % | 4.26 | 4.5 | 4.22 | 3.85 | 3.23 | |||||
EBITA Margin % | 3.89 | 4.17 | 3.92 | 3.54 | 2.99 | |||||
EBIT Margin % | 3.78 | 4 | 3.77 | 3.39 | 2.88 | |||||
Income From Continuing Operations Margin % | 2.77 | 2.85 | 2.88 | 2.47 | 1.71 | |||||
Net Income Margin % | 2.76 | 2.83 | 2.85 | 2.45 | 1.67 | |||||
Net Avail. For Common Margin % | 2.76 | 2.83 | 2.85 | 2.45 | 1.67 | |||||
Normalized Net Income Margin | 2.28 | 2.41 | 2.36 | 2.17 | 1.74 | |||||
Levered Free Cash Flow Margin | 2.48 | 2.46 | 4.86 | 5.15 | 2.41 | |||||
Unlevered Free Cash Flow Margin | 2.55 | 2.55 | 4.95 | 5.22 | 2.51 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.63 | 2.16 | 2.2 | 2.17 | 2.47 | |||||
Fixed Assets Turnover | 28.95 | 29.3 | 33.44 | 33.95 | 39.83 | |||||
Receivables Turnover (Average Receivables) | 5.22 | 4.06 | 4.05 | 4.07 | 4.69 | |||||
Inventory Turnover (Average Inventory) | 21.2 | 14.55 | 18.55 | 22.67 | 20.38 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.21 | 1.2 | 1.26 | 1.16 | 1.17 | |||||
Quick Ratio | 0.96 | 0.95 | 1.08 | 0.96 | 0.95 | |||||
Operating Cash Flow to Current Liabilities | 0.13 | 0.11 | 0.21 | 0.17 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 69.96 | 89.97 | 90.2 | 90.02 | 77.79 | |||||
Days Outstanding Inventory (Average Inventory) | 17.22 | 25.08 | 19.67 | 16.15 | 17.91 | |||||
Average Days Payable Outstanding | 52.09 | 75.28 | 80.59 | 87.21 | 80.18 | |||||
Cash Conversion Cycle (Average Days) | 35.09 | 39.77 | 29.28 | 18.96 | 15.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 25.5 | 18.11 | 13.44 | 16.72 | 22.53 | |||||
Total Debt / Total Capital | 20.32 | 15.33 | 11.85 | 14.32 | 18.39 | |||||
LT Debt/Equity | 16.08 | 11.79 | 9.01 | 11.78 | 17.01 | |||||
Long-Term Debt / Total Capital | 12.82 | 9.98 | 7.94 | 10.1 | 13.88 | |||||
Total Liabilities / Total Assets | 72.56 | 73.42 | 68.95 | 75.67 | 77.91 | |||||
EBIT / Interest Expense | 33.88 | 26.43 | 24.83 | 32.79 | 18.77 | |||||
EBITDA / Interest Expense | 44.95 | 34.89 | 31.74 | 42.94 | 24.27 | |||||
(EBITDA - Capex) / Interest Expense | 42.44 | 32.47 | 29.66 | 40.31 | 22.72 | |||||
Total Debt / EBITDA | 0.56 | 0.46 | 0.38 | 0.44 | 0.59 | |||||
Net Debt / EBITDA | -0.28 | -0.34 | -1.03 | -1.16 | -1.25 | |||||
Total Debt / (EBITDA - Capex) | 0.6 | 0.5 | 0.41 | 0.47 | 0.63 | |||||
Net Debt / (EBITDA - Capex) | -0.3 | -0.37 | -1.1 | -1.24 | -1.33 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.61 | 28.52 | 6.99 | 0.61 | 32.01 | |||||
Gross Profit, 1 Yr. Growth % | 20.44 | 9.14 | 10.23 | -0.86 | 10.54 | |||||
EBITDA, 1 Yr. Growth % | 27.67 | 1.71 | 0.45 | -8.12 | 10.78 | |||||
EBITA, 1 Yr. Growth % | 30.59 | 3.13 | 0.89 | -9.13 | 11.35 | |||||
EBIT, 1 Yr. Growth % | 31.66 | 1.93 | 0.97 | -9.44 | 12.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 20.95 | -1.23 | 8.25 | -13.79 | -8.61 | |||||
Net Income, 1 Yr. Growth % | 20.48 | -1.35 | 8.1 | -13.56 | -10.01 | |||||
Normalized Net Income, 1 Yr. Growth % | 31.38 | 1.79 | 5.05 | -8.58 | 6.13 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.25 | -1.12 | 8.86 | -11.72 | -4.84 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.58 | 29.84 | -9.08 | 7.76 | 18.1 | |||||
Inventory, 1 Yr. Growth % | 61.52 | 22.38 | -48.29 | 42.22 | 57.16 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.59 | -6.4 | -6.04 | 4.54 | 20.12 | |||||
Total Assets, 1 Yr. Growth % | 12.99 | 20.87 | -5.73 | 10.07 | 20.73 | |||||
Tangible Book Value, 1 Yr. Growth % | 32.2 | 12.17 | 18.28 | -20.44 | 24.4 | |||||
Common Equity, 1 Yr. Growth % | 17.95 | 16.91 | 8.78 | -13.96 | 10.82 | |||||
Cash From Operations, 1 Yr. Growth % | -5.32 | 7.94 | 69.6 | 1.58 | -29.61 | |||||
Capital Expenditures, 1 Yr. Growth % | -18.61 | 26.06 | -7.6 | -13.24 | 14.74 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -1.91 | -4.54 | 99.51 | 4.61 | -38.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.47 | -3.58 | 96.27 | 4.58 | -36.5 | |||||
Dividend Per Share, 1 Yr. Growth % | 30.77 | 2.41 | 3.09 | 1 | 5.52 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.37 | 9.05 | 17.26 | 3.75 | 15.24 | |||||
Gross Profit, 2 Yr. CAGR % | 14.4 | 14.65 | 9.68 | 4.54 | 4.68 | |||||
EBITDA, 2 Yr. CAGR % | 28.52 | 13.95 | 0.94 | -3.93 | 0.89 | |||||
EBITA, 2 Yr. CAGR % | 31.22 | 16.05 | 1.86 | -4.25 | 0.59 | |||||
EBIT, 2 Yr. CAGR % | 31.2 | 15.84 | 1.29 | -4.38 | 0.75 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 35.51 | 9.3 | 3.4 | -3.4 | -11.24 | |||||
Net Income, 2 Yr. CAGR % | 35.01 | 9.02 | 3.27 | -3.34 | -11.81 | |||||
Normalized Net Income, 2 Yr. CAGR % | 31.1 | 15.64 | 3.24 | -1.4 | -1.5 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 34.46 | 9.05 | 3.75 | -1.97 | -8.34 | |||||
Accounts Receivable, 2 Yr. CAGR % | 15.23 | 23.03 | 8.35 | -0.42 | 13.44 | |||||
Inventory, 2 Yr. CAGR % | 67.13 | 40.6 | -20.45 | -14.24 | 49.51 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.65 | -5.01 | -6.22 | -0.89 | 12.06 | |||||
Total Assets, 2 Yr. CAGR % | 19.06 | 16.86 | 6.15 | 1.86 | 15.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | 21.37 | 21.77 | 15.18 | -3 | -0.52 | |||||
Common Equity, 2 Yr. CAGR % | 22.61 | 17.43 | 12.77 | -3.26 | -2.35 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.36 | 1.09 | 35.3 | 31.26 | -15.44 | |||||
Capital Expenditures, 2 Yr. CAGR % | -21.01 | 1.29 | 7.93 | -10.46 | -0.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 6.5 | -3.24 | 42.02 | 45.89 | -19.57 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 6.59 | -2.53 | 41.42 | 44.21 | -18.51 | |||||
Dividend Per Share, 2 Yr. CAGR % | 156.21 | 15.73 | 2.75 | 2.04 | 3.23 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.61 | 8.59 | 8.36 | 11.43 | 12.42 | |||||
Gross Profit, 3 Yr. CAGR % | 16.52 | 12.62 | 13.16 | 6.05 | 6.5 | |||||
EBITDA, 3 Yr. CAGR % | 27.44 | 18.88 | 9.16 | -2.18 | 0.74 | |||||
EBITA, 3 Yr. CAGR % | 30.02 | 21.1 | 10.65 | -1.95 | 0.69 | |||||
EBIT, 3 Yr. CAGR % | 30.4 | 20.61 | 10.54 | -2.42 | 0.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 32.09 | 21.95 | 8.95 | -2.68 | -5.17 | |||||
Net Income, 3 Yr. CAGR % | 31.8 | 21.6 | 8.71 | -2.68 | -5.62 | |||||
Normalized Net Income, 3 Yr. CAGR % | 29.13 | 20.5 | 11.88 | -0.46 | 1.05 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 31.91 | 21.36 | 8.98 | -1.69 | -2.93 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.1 | 19.91 | 11.03 | 8.59 | 5.79 | |||||
Inventory, 3 Yr. CAGR % | 50.8 | 50.64 | 0.74 | -3.45 | 4.95 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 29 | 0.18 | -5.35 | -2.76 | 5.67 | |||||
Total Assets, 3 Yr. CAGR % | 11.47 | 19.66 | 8.38 | 7.44 | 7.8 | |||||
Tangible Book Value, 3 Yr. CAGR % | 21.05 | 18.22 | 20.6 | 1.82 | 5.39 | |||||
Common Equity, 3 Yr. CAGR % | 18.26 | 20.68 | 14.47 | 3.04 | 1.22 | |||||
Cash From Operations, 3 Yr. CAGR % | 24.86 | 6.88 | 20.12 | 22.97 | 6.64 | |||||
Capital Expenditures, 3 Yr. CAGR % | -25.49 | -7.69 | -1.76 | 0.35 | -2.75 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 25.63 | 2.68 | 25.54 | 29.1 | 9.59 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 26.15 | 3.08 | 25.37 | 28.45 | 9.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | 29.82 | 88.73 | 11.35 | 2.16 | 3.19 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.69 | 11.27 | 9.73 | 6.63 | 11.06 | |||||
Gross Profit, 5 Yr. CAGR % | 15.18 | 13.8 | 13.74 | 9.31 | 9.69 | |||||
EBITDA, 5 Yr. CAGR % | 22.87 | 19 | 16.09 | 9.11 | 5.77 | |||||
EBITA, 5 Yr. CAGR % | 24.8 | 20.64 | 17.92 | 10.17 | 6.51 | |||||
EBIT, 5 Yr. CAGR % | 24.29 | 19.69 | 17.87 | 9.85 | 6.51 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 23.94 | 17.77 | 19.76 | 11.1 | 0.37 | |||||
Net Income, 5 Yr. CAGR % | 23.78 | 17.59 | 19.55 | 10.94 | -0.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 23.37 | 18.66 | 18.07 | 11.14 | 6.58 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 25.2 | 19.06 | 19.83 | 11.43 | 1.69 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.94 | 17.4 | 5.78 | 11.2 | 12.26 | |||||
Inventory, 5 Yr. CAGR % | 50.63 | 43.23 | 16.76 | 20.25 | 17.97 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 29.34 | 22.34 | 13.55 | -0.25 | 1.26 | |||||
Total Assets, 5 Yr. CAGR % | 16.95 | 17.74 | 9.31 | 11.95 | 11.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.83 | 5.09 | 18.67 | 9.23 | 11.66 | |||||
Common Equity, 5 Yr. CAGR % | 11.59 | 12.11 | 16.03 | 10.47 | 7.42 | |||||
Cash From Operations, 5 Yr. CAGR % | 26.87 | 17.94 | 28.94 | 16.04 | 4.38 | |||||
Capital Expenditures, 5 Yr. CAGR % | 1.28 | -4.88 | -13.58 | -8.81 | -1.15 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 57.45 | 24.71 | 31.94 | 19.54 | 5.47 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 56.57 | 25.38 | 32.05 | 19.21 | 5.8 | |||||
Dividend Per Share, 5 Yr. CAGR % | 24.46 | 21.07 | 18.23 | 47.58 | 8.03 |
- Stock Market
- Equities
- CCC Stock
- Financials Computacenter plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















